Synthesis of a carbon-14 labeled 1-(indole-6-carbonyl-D-phenylglycinyl)-4-(1-methylpiperidin-4-YL)piperazine-[carbonyl-14C], LY517717-[14C] a factor Xa inhibitor

被引：10

作者：

Kuo, FJ ^{[1
]}

Clodfelter, DK ^{[1
]}

Priest, TR ^{[1
]}

Kau, DLK ^{[1
]}

机构：

[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2004年 / 47卷 / 09期

关键词：

factor Xa; D-phenylglycine-[C-14] synthesis; LY517717-[C-14;

D O I：

10.1002/jlcr.847

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Human Factor Xa is a trypsin-like serine protease, which serves a critical role in blood coagulation events. LY517717 is currently under clinical investigation as a Factor Xa inhibitor. To support the ADME studies, LY517717 was synthesized using D-phenylglycine with a carbon-14 labeled carboxyl moiety. This key component, D-phenylglycine-[carboxyl-C-14], was synthesized by a Strecker synthesis on benzaldehyde with potassium [C-14]cyanide, followed by a resolution of DL-phenyl-glycine methyl ester-[carbonyl-C-14] with (+)-tartaric acid in the presence of benzaldehyde. Copyright (C) 2004 John Wiley Sons, Ltd.

引用

页码：599 / 608

页数：10

共 26 条

[1] Synthesis of a [14C]-labelled photoactivatable cyclic tetrapeptide:: [carbonyl-14C]-4-benzoylbenzoyl MeSer1-tentoxin.
Gomis, JM
Santolini, J
Cavelier, F
Verducci, J
Pinet, E
André, F
Noel, JP
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2000, 43 (04): : 323 - 330
[2] Synthesis of carbon-14 labeled (R)-3-fluoro-4-(2′-(5", 6", 7", 8"-tetrahydro-5", 5", 8", 8"-tetramethyl-2"-naphthyl)-[2"-hydroxy-14C])[carbonyl-14C]acetamidobenzoic acid
Dischino, DD
Lee, CW
Belema, M
Zusi, C
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2003, 46 (02): : 159 - 165
[3] SYNTHESIS OF C-14-LABELED 1-(2-PYRIMIDYL)-4-(3,4-METHYLENEDIOXYBENZYL)PIPERAZINE METHANESULFONATE (PIRIBEDIL)
LINTERMANS, J
BENAKIS, A
HERBERT, M
PICHAT, L
HELVETICA CHIMICA ACTA, 1971, 54 (06) : 1713 - +
[4] Synthesis of (S)-1-(1H-indol-4-yloxy)-3[4-(3-methoxyphenyl)-4- hydroxypiperidin-1-yl]-propan-2-ol (LY333068) succinate, and its 3-[14C]- isotopomer based on chiral glycerol-[14C] derivatives
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, United States
J. Label. Compd. Radiopharm., 6 (465-475):
[5] Synthesis of carbon-14 labeled 4-[4-[2-[2-[bis(4-chlorophenyl)methoxy]ethyl sulfonyl][1-14C]ethoxy]phenyl]-1,1,1-trifluoro-2-butanone
Dischino, DD
Banville, J
Remillard, R
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2003, 46 (02): : 167 - 174
[6] Synthesis of carbon-14-labeled isotopomer of 6-(4-methanesulfonylphenyl)-5-[4-(2-piperidin-1-yl-ethoxy)phenoxy]-naphthaten-2-ol HCL salt (LY2066948-[14C] HCL salt)
Kuo, Fengjiun
Clodfelter, Dean K.
Priest, Tamara R.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2007, 50 (7-8): : 706 - 710
[7] Synthesis of 1-(4-methylsulfone-phenyl)-5-(4-fluoro-phenyl)-5-[14C]-1,2,3--triazole and 1-(4-sulfonamide-phenyl)-5-(4-fluoro-phenyl)-5-[14C]-1,2,3-triazole as novel carbon-14 anticonvulsant
Saemian, N.
Shirvani, G.
Matloubi, H.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2006, 268 (03) : 545 - 548
[8] Synthesis of 1-(4-methylsulfone-phenyl)-5-(4-fluoro-phenyl)-5-[ 14C]-1,2,3-triazole and 1-(4-sulfonamide-phenyl)-5-(4-fluoro-phenyl)- 5-[14C]-1,2,3-triazole as novel carbon-14 anticonvulsant
Saemian N.
Shirvani G.
Matloubi H.
J. Radioanal. Nucl. Chem., 2006, 3 (545-548): : 545 - 548
[9] Synthesis of (S)-1-(1H-Indol-4-yloxy)-3-[4-(3- Methoxyphenyl)-4-Hydroxypiperidin-1-yl]- Propan-2-ol (LY333068) Succinate, and its 3-[14C]-Isotopomer based on Chiral Glycerol-[14C] Derivatives
J Labelled Compd Radiopharm, 6 (465):
[10] Synthesis of (S)-1-(1H-indol-4-yloxy)-3-[4-(3-methoxyphenyl)-4-hydroxypiperidin-1-yl]-propan-2-ol (LY333068) succinate, and its 3-[14C]-isotopomer based on chiral glycerol-[14C] derivatives
Czeskis, BA
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1998, 41 (06): : 465 - 475

← 1 2 3 →